PRESS RELEASE published on 07/29/2025 at 20:16, 9 months 23 days ago Inside Information / Other news releases Poxel provides update on negotiations with creditors, announces reorganization proceedings & corporate governance change with trading suspension. Press release details Lyon Court filing for insolvency & governance impact Governance Creditors Reorganization Trading Suspension Poxel
PRESS RELEASE published on 07/29/2025 at 20:16, 9 months 23 days ago Informations privilégiées / Autres communiqués Poxel annonce dépôt requête redressement judiciaire, changement gouvernance, suspension cotation. Négociations créanciers et transition opérationnelle en cours Gouvernance Créanciers Transition Redressement Judiciaire Poxel
BRIEF published on 07/08/2025 at 18:51, 10 months 13 days ago Informations sur le capital et les droits de vote de Poxel Droits De Vote Capital Social Actions AMF Poxel
BRIEF published on 07/08/2025 at 18:51, 10 months 13 days ago Information on Poxel's capital and voting rights Share Capital Voting Rights Actions AMF Poxel
PRESS RELEASE published on 07/08/2025 at 18:46, 10 months 13 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel communique le nombre total d'actions et de droits de vote composant son capital social conformément à la réglementation AMF Capital Social Actions AMF Réglementé Poxel
BRIEF published on 06/19/2025 at 17:51, 11 months 2 days ago Key Scientific Presentations on Imeglimin at ADA 2025 Diabetes Therapeutic Potential Sumitomo Pharma Imeglimin Scientific Presentations
BRIEF published on 06/19/2025 at 17:51, 11 months 2 days ago Présentations scientifiques clés sur l'Imeglimine à l'ADA 2025 Diabète Présentations Scientifiques Sumitomo Pharma Potentiel Thérapeutique Iméglimine
PRESS RELEASE published on 06/19/2025 at 17:46, 11 months 2 days ago Inside Information / Other news releases Poxel presents new Imeglimin data at ADA 2025 diabetes conference, highlighting therapeutic potential. Key presentations by Japanese experts Diabetes Therapeutic Potential Poxel Imeglimin ADA 2025
PRESS RELEASE published on 06/19/2025 at 17:46, 11 months 2 days ago Informations privilégiées / Autres communiqués Des leaders d'opinion présentent le potentiel thérapeutique de l'Imeglimine lors de l'ADA 2025, le plus grand congrès sur le diabète. POXEL SA annonce cinq présentations à Chicago, Illinois Congrès Diabète Poxel SA Iméglimine ADA 2025
BRIEF published on 06/06/2025 at 19:10, 11 months 15 days ago Poxel : Détails sur le capital social et les droits de vote Droits De Vote Capital Social Actions Informations Réglementées Poxel
Published on 05/21/2026 at 23:00, 6 hours 50 minutes ago Silver Wolf Adopts Semi-Annual Financial Reporting
Published on 05/21/2026 at 23:00, 6 hours 50 minutes ago Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Published on 05/21/2026 at 23:00, 6 hours 50 minutes ago Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update
Published on 05/21/2026 at 22:15, 7 hours 35 minutes ago Linear Announces Acquisition, Share Consolidation and Private Placement
Published on 05/22/2026 at 05:10, 40 minutes ago ZPMC Launches Automated Production Line for Compact Enclosures
Published on 05/22/2026 at 04:50, 1 hour ago ZPMC Highlights Marine Engineering and Steel Bridge Manufacturing Capabilities on Media Open Day
Published on 05/22/2026 at 04:40, 1 hour 10 minutes ago Xinhua Silk Road: Anhui launches innovation and entrepreneurship contest to attract global sci-tech talents
Published on 05/22/2026 at 03:05, 2 hours 45 minutes ago BAI Capital Announces First Close of New US$800 Million Fund, Continues to Back Asia Growth and Globalization Opportunities
Published on 05/22/2026 at 02:40, 3 hours 10 minutes ago ESENTIA Completes US $2 Billion Investment-Grade Bond Offering, Achieving Simultaneous Triple-Agency Rating on Inaugural Corporate Bond
Published on 05/21/2026 at 17:45, 12 hours 5 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 12 hours 5 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 13 hours 15 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
